Loop of fate: structural and mechanistic insights into hnRNPA1 binding to the hepatitis C virus RNA

  1. Niyati Jain1,2
  1. 1CSIR-Institute of Genomics and Integrative Biology, New Delhi 110025, India
  2. 2Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India
  3. 3Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
  4. 4Structural Biology Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi 110067, India
  5. 5CSIR-Centre for Cellular and Molecular Biology, Hyderabad 500007, Telangana, India
  1. Corresponding author: niyati2002us{at}gmail.com
  1. Handling editor: Britt Glaunsinger

Abstract

Hepatitis C virus (HCV) is a major global health burden, associated with chronic liver diseases, including cirrhosis and hepatocellular carcinoma. Viral replication critically depends on conserved cis-acting replication elements (CREs), such as the 5BSL3.2 stem–loop near the 3′ end of the open reading frame. This element forms a long-range kissing-loop interaction with the SL2 domain of the 3′X tail, essential for efficient genome replication. However, the role of host RNA-binding proteins (RBPs) in regulating this RNA–RNA interaction remains poorly understood. To explore this, we investigated whether the host RBP hnRNPA1 modulates HCV replication by targeting the 5BSL3.2 element. Using an integrated approach combining structural biology, biophysics, and biochemical assays, we identify the terminal loop of 5BSL3.2 as a high-affinity binding site for the tandem RNA recognition motifs (RRMs) of hnRNPA1. Our data reveal that adenine-rich residues within the loop are critical for binding specificity. Our results uncover a structural mechanism by which hnRNPA1 binding perturbs the kissing-loop interaction between 5BSL3.2 and the SL2 element of the viral 3′X-tail, which impacts viral replication. This study highlights a previously unrecognized role of hnRNPA1 in modulating viral RNA structure and suggests a novel interface for host-directed antiviral intervention.

Keywords

Footnotes

  • Received September 15, 2025.
  • Accepted November 13, 2025.

This article, published in RNA, is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.

This article has not yet been cited by other articles.

| Table of Contents
OPEN ACCESS ARTICLE